New HCl Synthesis Unit Boosts Supply
Gujarat Alkalies announced construction of a new hydrochloric acid synthesis unit to support its phosphoric acid plant. The expansion increases domestic HCl supply, potentially easing price pressure.
Lincomycin Hydrochloride Price Trend Analysis 2026: Market Insights, Historical Prices, Supply Demand Analysis, Price Drivers & Latest News
Written ByPragati Agarwal
Lincomycin Hydrochloride Latest Development
Lincomycin Hydrochloride Price Trend H1 2026
Lincomycin Hydrochloride, a fermentation-derived antibiotic used across human medicine and veterinary applications to treat bacterial infections, saw its price trajectory in H1 2026 shaped by cautious pharmaceutical procurement, shifting feedstock dynamics, and an active regulatory environment.
Procurement activity from pharmaceutical formulators remained orderly through the first half of the year. Buyers maintained conservative inventory strategies, preferring to replenish in smaller tranches rather than build forward positions, a pattern that had taken root in late 2025. On the supply side, Chinese producers, who account for the bulk of global output, operated at measured utilisation rates, and corn, the principal fermentation feedstock, experienced mixed availability signals in Asian producing regions. In India, CDSCO compliance requirements and NPPA oversight maintained a cautious procurement climate among domestic formulators, while European importers maintained modest buffer stocks as part of broader supply-chain diversification strategies.
Analyst Insight
According to Procurement Resource, prices should stay broadly stable, driven by regulatory and corn feedstock trends.
Related Report
Need Latest Lincomycin Hydrochloride Prices?
Get real-time price assessments, periodic trends, forecasts and price driver insights across key global markets.
Our Clients
Procurement Resource Database
Turn price intelligence into action with the Procurement Resource Database. Log in or subscribe to unlock live price trends, historical charts, supplier databases, cost curves, and analyst-backed insights across chemicals, agriculture, energy, packaging, and more. Use these tools to benchmark your contracts, plan budgets with confidence, and stay ahead of market moves on every product you buy.
0
+Products
0
+Regions
0
+Subscriptions
During the first half of 2025, Lincomycin Hydrochloride price curve moved within a mixed range, reflecting the impact of evolving trade conditions and policy measures on pharmaceutical intermediates.
In the early part of the period, downstream demand from the pharmaceutical industry remained steady. Consumption was supported by the use of Lincomycin Hydrochloride as an active pharmaceutical ingredient for antibiotic formulations, with procurement activity aligned to regular manufacturing schedules. Supply remained consistent, though procurement costs showed sensitivity to broader movements in raw material availability.
As the quarter progressed, regulatory measures significantly influenced market conditions. The directive issued by the Central Drugs Standard Control Organisation (CDSCO) on the suspension of several fixed-dose combination (FDC) drugs created ripples across the domestic market.
While Lincomycin Hydrochloride was not directly banned, the heightened scrutiny over licensing and compliance slowed procurement activity in some downstream segments. Manufacturers adopted a cautious approach in securing raw materials, preferring smaller lots to align with anticipated production volumes. This tempered the pace of demand growth and affected spot price sentiment.
Toward the later part of the half-year, sentiment improved slightly as downstream pharmaceutical companies resumed steady purchasing, though overall activity continued to reflect cautious operating strategies. The market closed the period with a balanced structure between supply and demand, albeit under close observation from regulators.
About Lincomycin Hydrochloride
Lincomycin hydrochloride belongs to the category of antibiotic medicines that is used in the treatment of bacterial infections in humans as well as animals. It inhibits the growth of bacteria by inhibiting the protein synthesis process in them. This pharmaceutical compound is available in various forms, including capsules and injectable solutions. It is commonly used in clinical and veterinary medicine to combat a range of bacterial infections, including respiratory, skin, and soft tissue infections.
Lincomycin Hydrochloride Product Detail
HS Code
29419090
Chemical Formula
C18H34N2O6S.HCl.H2O
CAS Number
859-18-7
Molecular Weight
461.01 g/mol
Industrial Uses
Pharmaceutical Manufacturing, Veterinary Medicine, Biomedical Research, Quality control and testing
Supplier Database
Anhui Wanbei Pharmaceutical Co Ltd, Hangzhou Think Chemical Co Ltd, Hengdian Group Holding Co Ltd, Jiangxi Guoyao Pharmaceutical Limited Liability Company, Livzon Group Fuzhou Fuxing Pharmaceutical Co Ltd, Xinyu Pharmaceutical Co Ltd
Regional Coverage
Asia Pacific
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Iran, Thailand, South Korea, Iraq, Saudi Arabia, Malaysia, Nepal, Taiwan, Sri Lanka, UAE, Israel, Hongkong, Singapore, Oman, Kuwait, Qatar, Australia, and New Zealand
Europe
Germany, France, United Kingdom, Italy,Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
North America
United States and Canada
Latin America
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
Africa
South Africa, Nigeria, Egypt, Algeria, Morocco
CurrencyUS$ (Data can also be provided in local currency)
Supplier Database AvailabilityYes
Customization ScopeThe report can be customized as per the requirements of the customer
Post-Sale Analyst Support360-degree analyst support after report delivery
Note: Our supplier search experts can assist your procurement teams in compiling and validating a list of suppliers indicating they have products, services, and capabilities that meet your company's needs.
Frequently Asked Questions
Lincomycin hydrochloride prices are expected to remain broadly stable through 2026, supported by steady pharmaceutical demand and measured production output from Chinese manufacturers. The outlook rests on two key conditions: corn feedstock availability, which underpins fermentation costs, and regulatory compliance requirements in India and Europe that shape procurement behaviour. Any meaningful shift would require a disruption to corn supply, a change in Chinese operating rates, or a significant policy adjustment in major consuming markets.
Lincomycin hydrochloride prices are shaped by restrained Chinese utilisation rates, which limit refined supply, and by corn, the principal fermentation feedstock, whose mixed availability across Asian producing regions can pressure production costs. In India, CDSCO compliance requirements and NPPA oversight prompt domestic formulators to hold back on larger procurement commitments. European importers maintain modest buffer stocks amid supply-chain diversification, while pharmaceutical buyers favour smaller, more frequent replenishment tranches, keeping demand steady.
China dominates lincomycin hydrochloride production, with key suppliers including Jiangxi Guoyao Pharmaceutical, Livzon Group Fuzhou Fuxing Pharmaceutical, and Xinyu Pharmaceutical. India and Europe represent the main consumption markets, where domestic formulators operate under CDSCO and NPPA oversight in India, while European importers hold modest buffer stocks as part of supply-chain diversification. This concentration of output in China creates meaningful supply-chain concentration risk for global buyers.
Lincomycin hydrochloride is produced via a fermentation-based route. The sole raw material input is the actinomycete Streptomyces lincolnensis, which is cultured to biosynthesize lincomycin. The intermediate lincomycin is then extracted using Sarcina lutea as the assay organism on agar trays, yielding the final hydrochloride product. The finished compound is used downstream in pharmaceutical manufacturing, veterinary medicine, and biomedical research.
Lincomycin hydrochloride demand is driven by pharmaceutical manufacturing as an antibiotic for gram-positive bacterial infections, including staphylococcal skin infections, post-operative infections, and penicillin-allergy alternatives. Veterinary medicine and biomedical research into antibiotic resistance and protein synthesis also underpin consumption. These end-use sectors translate into steady procurement from formulators, with regulatory compliance requirements in key markets shaping buying patterns and sustaining price stability.
China dominates global lincomycin hydrochloride production, while India's formulators operate under CDSCO and NPPA oversight, concentrating the API supply chain in a narrow Asian corridor. This concentration compresses buyer negotiating power, extends lead times for non-Asian markets, and ties freight costs to Asian shipping dynamics. Conservative inventory strategies, favoring small, frequent tranches over stockpiling, leave limited buffers. A policy shift or production curtailment in either market would tighten availability, push prices higher, and force buyers to scramble amid modest European buffer stocks.
Procurement Resource assesses lincomycin hydrochloride prices through a structured, data-driven methodology that combines primary engagement with producers, suppliers and traders, secondary market data, monitoring of feedstock and input costs, trade-flow and inventory tracking, and exchange or spot benchmarks. These inputs are validated and translated into a transparent price assessment and outlook. The detailed methodology is available on the Procurement Resource website.
Our Price Analysis Methodology
About the Author
Pragati Agarwal
Senior Business Insights Analyst
Delivering price trend analysis and procurement market insights at Procurement Resource, with expertise in identifying commodity patterns, supporting purchasing strategies, and improving cost efficiency through actionable market intelligence.
Schedule A Demo
Experience how Procurement Resource transforms raw material price data into clear, decision ready intelligence. Optimise your performance with reliable, expert market data and analysis. Schedule your demo today to experience a live walk-through where our experts will showcase interactive price charts, forecasted prices, and insights driving the prices for your key commodities, tailored to your workflows. Contact us now!
Our Team will be happy to assist you
We are just a text away
Still Need Help?
Unlock full access to Procurement Resource's price databases, interactive charts, and short-term forecasts for thousands of commodities. Elevate your sourcing decisions by comparing prices across regions, downloading historical data, and layering in analyst-backed insights, all with our flexible plans that scale as your portfolio grows.
Still have any Questions
Contact Us
Price Trend Dashboard - What's Included
Price trends across a diverse portfolio of categories and products, spanning board to niche chemicals
Coverage extendable to grade-specific chemicals based on procurement requirements
Regular price tracking supported by robust historical datasets
News, policy updates, and key market drivers impacting price movements
Short-term and long-term price outlooks and forecasts
Supply–demand dynamics and capacity-driven market analysis
Why Procurement Database
Commodity Market Intelligence
Track prices, market movements, supply-demand dynamics, and industry developments across hundreds of commodities through a centralized intelligence platform built for informed procurement decisions.
Price Forecasts & Market Outlooks
Understand market fluctuations using analyst-backed forecasts, historical pricing patterns, and evolving industry trends to strengthen sourcing strategies and budget planning.
Cost & Procurement Optimization
Leverage cost models, pricing benchmarks, and procurement insights to evaluate purchasing opportunities, improve negotiations, and enhance operational efficiency.
Global & Regional Market Insights
Access region-specific price trends, trade activities, capacity changes, and supply chain developments influencing commodity markets worldwide.
1/4